King‐Hwa Ling

2.9k total citations
114 papers, 1.9k citations indexed

About

King‐Hwa Ling is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, King‐Hwa Ling has authored 114 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 22 papers in Public Health, Environmental and Occupational Health and 20 papers in Genetics. Recurrent topics in King‐Hwa Ling's work include Down syndrome and intellectual disability research (19 papers), Genetics and Neurodevelopmental Disorders (15 papers) and MicroRNA in disease regulation (12 papers). King‐Hwa Ling is often cited by papers focused on Down syndrome and intellectual disability research (19 papers), Genetics and Neurodevelopmental Disorders (15 papers) and MicroRNA in disease regulation (12 papers). King‐Hwa Ling collaborates with scholars based in Malaysia, Australia and United States. King‐Hwa Ling's co-authors include Parham Jabbarzadeh Kaboli, Pike-See Cheah, Patimah Ismail, Asmah Rahmat, Kai-Leng Tan, Hamish S. Scott, Han-Chung Lee, Rozita Rosli, Zamberi Sekawi and Zurina Hassan and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

King‐Hwa Ling

107 papers receiving 1.9k citations

Peers

King‐Hwa Ling
Yan Yan China
Yong Shen China
Sarah Gerlo Belgium
Slava Rom United States
King‐Hwa Ling
Citations per year, relative to King‐Hwa Ling King‐Hwa Ling (= 1×) peers Jingjing Fan

Countries citing papers authored by King‐Hwa Ling

Since Specialization
Citations

This map shows the geographic impact of King‐Hwa Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by King‐Hwa Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites King‐Hwa Ling more than expected).

Fields of papers citing papers by King‐Hwa Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by King‐Hwa Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by King‐Hwa Ling. The network helps show where King‐Hwa Ling may publish in the future.

Co-authorship network of co-authors of King‐Hwa Ling

This figure shows the co-authorship network connecting the top 25 collaborators of King‐Hwa Ling. A scholar is included among the top collaborators of King‐Hwa Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with King‐Hwa Ling. King‐Hwa Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Christopher Thiam Seong, et al.. (2025). The Regulatory Roles of REST in the Synaptic Development, Function and Related Neurological Disorders. Journal of Neurochemistry. 169(6). e70132–e70132. 1 indexed citations
3.
Mahadzir, Hazlina, et al.. (2025). The Interplay of Inflammation and Gut-Microbiota Dysbiosis in Alzheimer’s Disease: Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 26(18). 8905–8905. 5 indexed citations
4.
Khan, Abdul Hanif Khan Yusof, et al.. (2025). On the rising potential of interdisciplinary rehabilitation in neurological disorders: A mini-review. Medicine. 104(12). e41947–e41947. 1 indexed citations
5.
Zeraatkar, Dena, King‐Hwa Ling, Tyler Pitre, et al.. (2025). Interventions for the management of post-COVID-19 condition (long COVID): protocol for a living systematic review and network meta-analysis. BMJ Open. 15(2). e086407–e086407.
6.
Zeraatkar, Dena, Tyler Pitre, King‐Hwa Ling, et al.. (2024). Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis. SHILAP Revista de lepidopterología. 3(1). e000998–e000998.
7.
Fakurazi, Sharida, et al.. (2024). Chromosomal and cellular therapeutic approaches for Down syndrome: A research update. Biochemical and Biophysical Research Communications. 735. 150664–150664. 2 indexed citations
8.
Ling, King‐Hwa, et al.. (2024). Molecular genetics of Dupuytren’s contracture. EFORT Open Reviews. 9(8). 723–732. 1 indexed citations
9.
Pirhoushiaran, Maryam, et al.. (2024). Identifying Genetic Profiles in Peripheral Blood Mononuclear Cells in Women with Polycystic Ovary Syndrome: An Observational Case-Control Study. Archives of Medical Research. 56(3). 103129–103129. 8 indexed citations
10.
Fakurazi, Sharida, et al.. (2023). REST Targets JAK–STAT and HIF-1 Signaling Pathways in Human Down Syndrome Brain and Neural Cells. International Journal of Molecular Sciences. 24(12). 9980–9980. 8 indexed citations
11.
Ling, King‐Hwa, et al.. (2023). Neural fate commitment of rat full-term amniotic fluid stem cells via three-dimensional embryoid bodies and neurospheres formation. IBRO Neuroscience Reports. 14. 235–243. 1 indexed citations
12.
Thilakavathy, Karuppiah, et al.. (2023). Novel PAX4 variant in a child and family with diabetes mellitus – case report and review of the literature. Journal of Pediatric Endocrinology and Metabolism. 36(10). 988–992.
13.
Pirhoushiaran, Maryam, et al.. (2023). Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks. Iranian journal of pharmaceutical research. 22(1). e139985–e139985. 12 indexed citations
15.
Lee, Han-Chung, Chelsee Hewitt, Sharmili Vidyadaran, et al.. (2019). Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model. International Journal of Neuroscience. 129(9). 871–881. 12 indexed citations
16.
Ling, King‐Hwa, et al.. (2019). Annexin II as a Dengue Virus Serotype 2 Interacting Protein Mediating Virus Interaction on Vero Cells. Viruses. 11(4). 335–335. 13 indexed citations
17.
Yap, Ivan Kok Seng, et al.. (2019). Perturbed metabolic profiles associated with muscle weakness seen in adult Ts1Cje mouse model of Down syndrome. Jūigaku kenkyū/Japanese journal of veterinary research. 67(1). 111–118. 1 indexed citations
18.
Tor, Yin Sim, Pike-See Cheah, Johnson Stanslas, et al.. (2019). Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients. PLoS ONE. 14(1). e0211241–e0211241. 37 indexed citations
19.
Kaboli, Parham Jabbarzadeh, Asmah Rahmat, Patimah Ismail, & King‐Hwa Ling. (2015). MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. Pharmacological Research. 97. 104–121. 110 indexed citations
20.
Tsai, Ming-Cheng, et al.. (1993). Effects of territrem-B on motor nerve terminals of mouse skeletal muscle. 8(3). 141–145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026